...
首页> 外文期刊>International Journal of Radiation Oncology, Biology, Physics >Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer.
【24h】

Usefulness of magnetic resonance volumetric evaluation in predicting response to preoperative concurrent chemoradiotherapy in patients with resectable rectal cancer.

机译:磁共振容积评估在预测可切除直肠癌患者术前同时放化疗的反应中的有用性。

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: We performed magnetic resonance (MR) volumetry before and after neoadjuvant chemoradiation for evaluating response to therapy in T3 and T4 rectal cancer. To investigate the utility of MR volumetry for predicting the response to neoadjuvant chemoradiation, we compared results from MR volumetry before chemoradiation with those after chemoradiation. Methods and Materials: A total 112 patients with T3 or T4 rectal cancer who successfully underwent MR volumetry and completed neoadjuvant chemoradiation followed by radical resection for cure were identified. MR volumetries were performed before and after chemoradiation. We compared pre- and postchemoradiation tumor volume and % volume reduction rates of patients whose tumors were down-staged with those of patients that were not down-staged. The same analyses were also performed between those patients having a complete histologic regression and those with residual disease in the operative specimen. We assessed the difference of % volume reduction rateaccording to Dworak's rectal cancer regression grades. Results: Fifty-seven patients (50.9%) demonstrated a tumor down-staging after chemoradiation therapy. Both pre- and posttreatment MR tumor volumes were significantly less in patients whose tumors were down-staged than in patients that were not down-staged (p = 0.04, 0.031), and % volume reduction rates were significantly higher in patients whose tumors were down-staged (p = 0.024). Sixteen patients (14.3%) showed pathologically complete tumor regression. The differences of MR tumor volumes before and after chemoradiation and % volume reduction rates were not significantly different between patients having a complete histologic regression and those with residual disease (p = 0.688, 0.451, and 0.480). The differences of % volume reduction rates according to Dworak's grades were statistically significant (p = 0.03). Conclusion: The MR volumetric examinations before and after chemoradiation demonstrated the significant difference of tumor volume and % volume reduction rate between patients whose tumors were down-staged and those that were not down-staged. The volume reduction rates were significantly different among groups according to Dworak's grades. However, the MR volumetric evaluation could not identify any differences between those patients having a complete histologic regression and those with residual disease.
机译:目的:我们在新辅助化学放疗前后进行了磁共振(MR)检查,以评估T3和T4直肠癌对治疗的反应。为了调查MR量器在预测对新辅助化学放疗的反应中的效用,我们比较了MR量器在化学放疗前和化学放疗后的结果。方法和材料:确定总共112例T3或T4直肠癌患者,这些患者成功进行了MR容量检查并完成了新辅助化学放疗,然后进行了根治性切除以治愈。在放化疗前后进行MR容量测定。我们比较了放化疗前和放化疗后肿瘤体积和未放化疗患者的体积缩小百分比。在组织学完全消退的患者和手术标本中残留疾病的患者之间也进行了相同的分析。我们根据Dworak的直肠癌消退等级评估了缩小体积百分比的差异。结果:57例患者(50.9%)在放化疗后表现出肿瘤分期降低。肿瘤下调患者的治疗前和治疗后MR肿瘤体积均显着低于未下调肿瘤的患者(p = 0.04,0.031),并且肿瘤下移的患者体积缩小率显着更高分阶段(p = 0.024)。 16名患者(14.3%)在病理上显示出肿瘤完全消退。在具有完全组织学消退的患者和具有残留疾病的患者之间,放化疗前后的MR肿瘤体积和缩小率百分比的差异无显着差异(p = 0.688、0.451和0.480)。根据Dworak的等级,减少体积百分比的差异具有统计学意义(p = 0.03)。结论:放化疗前后的MR容积检查表明,肿瘤下移和未下移的患者的肿瘤体积和缩小率百分比有显着差异。根据Dworak的等级,各组的体积减少率显着不同。但是,MR容积评估无法确定组织学完全消退的患者和残存疾病的患者之间的任何差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号